The cell death and DNA damages caused by the Tet-On regulating HSV-tk/GCV suicide gene system in MCF-7 cells

Biomed Pharmacother. 2014 Sep;68(7):887-92. doi: 10.1016/j.biopha.2014.07.018. Epub 2014 Jul 28.

Abstract

Ganciclovir (GCV) affects the molecular mechanism of cell death and DNA damage by the rAAV (recombinant adeno-associated virus)-mediated Tet-On/HSV-tk/GCV suicide gene system in human breast cancer cell line MCF-7. A rAAV/TRE/Tet-On/HSV-tk combining a Tet-On regulating system and a suicide gene HSV-tk was used to transfect human breast cancer cell line MCF-7, and therapeutic effects on this system were studied. Afterwards, we used RT-PCR, western blotting, and a modified comet-assay to explore the potential mechanism of the HSV-tk/GCV suicide gene system in breast cancer treatments. MTT assay has shown that the cell number of GCV+rAAV+Dox group was significantly decreased compared with that of other groups after treatment and flow cytometric analysis detected that there was a substantial increase of S phase cells in this group, which means the HSV-tk/GCV suicide gene system probably works on the cell cycle. RT-PCR detected the expression level of p21 increased and PCNA had an opposite trend. Western blotting detected the protein expression of p21 and p53 increased and PCNA, CDK1, cyclin B decreased in GCV+rAAV+Dox group. The modified comet-assay shown that the very small extra fragments generated by the GCV+rAAV+Dox group treatment are visible as a small cloud extending from the comet in the direction of electrophoresis. The therapeutic mechanism of the HSV-tk/GCV suicide gene system on human breast cancer cell line MCF-7 is probably by upregulating the expression of p21 through a p53-dependent DNA damage signalling pathway, leading the decrease of protein expression of PCNA, cyclin B, CDK1 in MCF-7 cells and promoting the cell cycle arrest at G1/S phase. In summary, the HSV-tk/GCV suicide gene system arouses the death of MCF-7 cells from blocking the cell cycle and DNA damage.

Keywords: Ganciclovir; HSV-tk; Human breast cancer; Suicide gene system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • CDC2 Protein Kinase
  • Cell Death / drug effects
  • Cell Death / genetics*
  • Cell Line, Tumor
  • Cyclin B1 / genetics
  • Cyclin-Dependent Kinase Inhibitor p21 / genetics
  • Cyclin-Dependent Kinases / genetics
  • DNA Damage / drug effects
  • DNA Damage / genetics*
  • Dependovirus / genetics
  • G1 Phase / drug effects
  • G1 Phase / genetics
  • Ganciclovir / pharmacology
  • Genes, Transgenic, Suicide / drug effects
  • Genes, Transgenic, Suicide / genetics*
  • Genetic Vectors / genetics
  • Humans
  • MCF-7 Cells
  • Proliferating Cell Nuclear Antigen / genetics
  • S Phase / drug effects
  • S Phase / genetics
  • Simplexvirus / genetics*
  • Tumor Suppressor Protein p53 / genetics

Substances

  • Antiviral Agents
  • CCNB1 protein, human
  • Cyclin B1
  • Cyclin-Dependent Kinase Inhibitor p21
  • Proliferating Cell Nuclear Antigen
  • Tumor Suppressor Protein p53
  • CDC2 Protein Kinase
  • CDK1 protein, human
  • Cyclin-Dependent Kinases
  • Ganciclovir